Alexandria Real Estate Equities
ARE
$117.73
Share price
-1.60%
Change (1 day)
-5.09%
Change (1 year)
Categories
Alexandria Real Estate Equities, Inc. is a real estate investment trust that invests in office buildings and laboratories.
Alexandria Real Estate Equities (ARE) - Cash on Hand
Cash on Hand as of December 2023 : $0.61 B
According to Alexandria Real Estate Equities
's latest financial reports the company has $0.61 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Alexandria Real Estate Equities - Cash on Hand chart (from 2001 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.61 B | -25.09% |
| 2022-12-31 | $0.82 B | 128.37% |
| 2021-12-31 | $0.36 B | -36.44% |
| 2020-12-31 | $0.56 B | 199.73% |
| 2019-12-31 | $0.18 B | -19% |
| 2018-12-31 | $0.23 B | -7.94% |
| 2017-12-31 | $0.25 B | 103.45% |
| 2016-12-31 | $0.12 B | -0.05% |
| 2015-12-31 | $0.12 B | 45.44% |
| 2014-12-31 | $86.01 M | 49.08% |
| 2013-12-31 | $57.69 M | -59.07% |
| 2012-12-31 | $0.14 B | 79.49% |
| 2011-12-31 | $78.53 M | -13.91% |
| 2010-12-31 | $91.23 M | 29.17% |
| 2009-12-31 | $70.62 M | -0.75% |
| 2008-12-31 | $71.16 M | 786.19% |
| 2007-12-31 | $8.03 M | 172.39% |
| 2006-12-31 | $2.94 M | -24.62% |
| 2005-12-31 | $3.91 M | 23.84% |
| 2004-12-31 | $3.15 M | -36.65% |
| 2003-12-31 | $4.98 M | 31.53% |
| 2002-12-31 | $3.79 M | 59.51% |
| 2001-12-31 | $2.37 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $12.69 B | 1,952.77% | 🇺🇸 USA |
 Eli Lilly LLY | $2.92 B | 373.59% | 🇺🇸 USA |
 Amgen AMGN | $10.94 B | 1,670.33% | 🇺🇸 USA |
 Gilead Sciences GILD | $7.26 B | 1,075.04% | 🇺🇸 USA |
 Illumina ILMN | $1.05 B | 70.50% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $12.28 B | 1,886.44% | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | $2.43 B | 294.60% | 🇺🇸 USA |